[

randeep guleria

]

Latest from randeep guleria

AIIMS director Randeep Guleria takes 'precautionary’ jab against Covid-19

The country today started a nationwide 'precautionary dose' drive for frontline workers, healthcare workers and senior citizens above 60 years of age with co-morbidities.
AIIMS Director Randeep Singh Guleria takes 'precautionary dose' of COVID-19 vaccine, in New Delhi on Monday(ANI)
AIIMS Director Randeep Singh Guleria takes 'precautionary dose' of COVID-19 vaccine, in New Delhi on Monday(ANI)
Published on Jan 10, 2022 11:50 PM IST
Copy Link
ANI | , New Delhi

What do Omicron's 30 mutations signify? AIIMS chief Dr Randeep Guleria explains

Omicorn might render many vaccines less effective as it has many mutations in spike protein, AIIMS director Dr Randeep Guleria said. 
Omicron, the new Covid variant, can have many possibilities, Dr Randeep Guleria said. 
Omicron, the new Covid variant, can have many possibilities, Dr Randeep Guleria said. 
Updated on Nov 29, 2021 11:21 AM IST
Copy Link
By | Written by Poulomi Ghosh

Third dose of vaccine not needed in India yet: AIIMS chief on booster shots

VK Paul, a member of NITI Aayog also present at the book launch event, added that a decision on the ‘third dose' (booster shot), if necessary, will be decided based on science and studies are currently ongoing on this matter.
Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS). (File Photo / PTI)
Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS). (File Photo / PTI)
Updated on Nov 24, 2021 05:55 PM IST
Copy Link
Written by Joydeep Bose | Edited by Amit Chaturvedi, Hindustan Times, New Delhi

New AIIMS master plan: 3,000 more beds, 50 OTs in 7 years

The master plan details the creation of over 4,000 hostel units to replace the currently ageing buildings, as well as a smart library for students. Dr Guleria said the research needs of the institute will also be kept in mind while implementing the comprehensive redevelopment plan
AIIMS hospital already has over 2,000 beds for the treatment of patients. (HT)
AIIMS hospital already has over 2,000 beds for the treatment of patients. (HT)
Updated on Sep 26, 2021 04:00 AM IST
Copy Link

Half of total Covid-19 deaths logged between April, May

Forty-one per cent of the total Covid-19 deaths in April and May in India came from Maharashtra, Karnataka and Delhi, according to the data shared by the National Centre for Disease Control (NCDC) with HT in reply to a Right To Information application.
A worker stoking a funeral pyre during cremations of Covid-19 victims at Sarai Kale Khan crematorium, in New Delhi.
A worker stoking a funeral pyre during cremations of Covid-19 victims at Sarai Kale Khan crematorium, in New Delhi.
Updated on Jul 26, 2021 01:09 AM IST
Copy Link
By, Hindustan Times, New Delhi

‘Avoid crowd, non-essential travel, maintain appropriate behaviour’: Dr Guleria

"We should avoid crowd, non-essential travel and maintain Covid-appropriate behaviour. With this, I think we can delay and also flatten the third wave,” AIIMS chief Dr Randeep Guleria said.
AIIMS director Dr Randeep Guleria said avoiding crowds and non-essential travel can delay third Covid-19 wave. In picture - Tourists in Shimla, Himachal Pradesh.(PTI)
AIIMS director Dr Randeep Guleria said avoiding crowds and non-essential travel can delay third Covid-19 wave. In picture - Tourists in Shimla, Himachal Pradesh.(PTI)
Updated on Jul 23, 2021 04:08 PM IST
Copy Link
Written by Srivatsan K C | Edited by Poulomi Ghosh, Hindustan Times, New Delhi

Covid-19 third wave to hit India in next 6-8 weeks: AIIMS Director

  • The AIIMS Director also said that "a national-level lockdown cannot be a solution" as it adversely affects the economy which is still reeling under the impact of past restrictions.
A healthcare worker collects a swab sample from a woman during a rapid antigen testing campaign for coronavirus disease (Covid-19), outside a shopping mall in Mumbai.(REUTERS)
A healthcare worker collects a swab sample from a woman during a rapid antigen testing campaign for coronavirus disease (Covid-19), outside a shopping mall in Mumbai.(REUTERS)
Updated on Jun 19, 2021 05:59 PM IST
Copy Link
By | Written by Shivani Kumar | Edited by Avik Roy, Hindustan Times, New Delhi

‘Third wave of Covid might not impact children, however...’: AIIMS director

“It has been said that children will be infected the most in the third wave, but the Paediatrics Association has said that this is not based on facts. It might not impact children so people should not fear,” All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria said, according to ANI.
Guleria notified reporters that children have been only mildly affected in both the first and second wave of the pandemic but there has been a lot of collateral damage.(ANI)
Guleria notified reporters that children have been only mildly affected in both the first and second wave of the pandemic but there has been a lot of collateral damage.(ANI)
Published on May 24, 2021 07:28 PM IST
Copy Link
By | Written by Harshit Sabarwal | Edited by Avik Roy, New Delhi

News updates from HT: Row after several killed in violence post-Bengal polls

Here are today’s top news, analysis, and opinion at 9am on May 4, 2021 (Tuesday). Know all about the latest news and other news updates from Hindustan Times.
BJP office and shops vandalized by unidentified people, in Ghoshpara road of Bhatpara on Monday. (ANI Photo)
BJP office and shops vandalized by unidentified people, in Ghoshpara road of Bhatpara on Monday. (ANI Photo)
Published on May 04, 2021 08:56 AM IST
Copy Link

New strains not more infectious, need to aggressively monitor situation: Guleria

"Currently we have vaccines with efficacy of 70 per cent , 80 per cent, 90 per cent so even if there is slight fall in efficacy they will still be effective in preventing the virus from further spreading," Guleria told in an interview to ANI.
When asked about the new strains of the virus that have been found in several parts of the country, Guleria said authorities are closely monitoring the situation.(ANI photo)
When asked about the new strains of the virus that have been found in several parts of the country, Guleria said authorities are closely monitoring the situation.(ANI photo)
Published on Feb 24, 2021 11:28 PM IST
Copy Link
ANI |

AIIMS chief calls for public-private partnership for rollout of Covid-19 vaccine

AIIMS director Randeep Guleria said the vaccine is the only weapon available to gain immunity and help reduce mortality rate due to the infectious disease.
"We need to develop a mechanism where public and private sector actually start rolling out the vaccine at a large scale," Dr Guleria said.(PTI)
Published on Feb 20, 2021 05:10 PM IST
Copy Link
PTI | , New Delhi

India’s vaccine jabs may start next week: Officials

Prime Minister Narendra Modi said the world’s biggest inoculation drive against coronavirus is set to begin in the country, lauding scientists and technicians for the “Made in India” vaccines.
A man applies finishing touches to graffiti representing a vaccine, amidst the spread of coronavirus disease (Covid-19) in Kolkata, India, January 2, 2021.(REUTERS)
A man applies finishing touches to graffiti representing a vaccine, amidst the spread of coronavirus disease (Covid-19) in Kolkata, India, January 2, 2021.(REUTERS)
Updated on Jan 05, 2021 07:01 AM IST
Copy Link
Hindustan Times, New Delhi | By

Experts flag concern over ‘limited data’ for Covaxin

Early-stage trials found the vaccine to be safe and able to invoke a robust immune response, but Phase 2 data is under peer review and has not been published. Phase 3 trials were announced on November 16, and around 22,500 of 25,800 volunteers have enrolled of which around half have received two doses.
A medic fills a syringe with Covxin before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad, India.(Reuters/ File photo)
A medic fills a syringe with Covxin before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad, India.(Reuters/ File photo)
Updated on Jan 04, 2021 02:41 AM IST
Copy Link
Hindustan Times, New Delhi | By

DCGI gives licensing permission to Bharat Biotech to manufacture Covaxin

The DCGI gave final approval to two Covid-19 vaccines, paving the way for a huge inoculation program to stem the pandemic in the second worst-hit country.
The DCGI granted the approval on the basis of recommendations of a Covid-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).(PTI)
The DCGI granted the approval on the basis of recommendations of a Covid-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).(PTI)
Updated on Jan 03, 2021 08:58 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com| Edited by Susmita Pakrasi

Covid vaccine to be taken 28 days apart, antibodies will develop 2 weeks after last dose: AIIMS Director

AIIMS Director also informed that after all doses of the vaccine are administered, a QR-code based certificate will also be sent to the mobile number of the beneficiary and recommended that after vaccination, patients should take rest for at least 30 minutes.
A doctor administers a mock Covid-19 vaccine during a dry run at Govt Rajindra Hospital in Patiala, Punjab.(HT photo)
A doctor administers a mock Covid-19 vaccine during a dry run at Govt Rajindra Hospital in Patiala, Punjab.(HT photo)
Updated on Jan 03, 2021 07:12 PM IST
Copy Link
New Delhi, Delhi | ByAsian News International | Posted by Shivani Kumar

Covishield and Covaxin: What’s next after Drug Controller’s approval?

The approval does not mean the ongoing trials of both these vaccines will be stopped. Trials will go on along with emergency vaccination drive. More data from ongoing trials will help experts understand the efficacy of the vaccines better.
Health workers preparing for Covid-19 vaccination mock drill at Rajawadi Municipal Corporation Hospital in Mumbai.(PTI)
Health workers preparing for Covid-19 vaccination mock drill at Rajawadi Municipal Corporation Hospital in Mumbai.(PTI)
Updated on Jan 03, 2021 06:31 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Poulomi Ghosh

Bharat Biotech’s Covaxin can be used as backup, says AIIMS Director Dr Randeep Guleria

The DCGI gave approval for the emergency use of two Covid-19 vaccines, one developed by AstraZeneca and Oxford University and the other by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
AIIMS Director Dr Randeep Guleria.(PTI)
AIIMS Director Dr Randeep Guleria.(PTI)
Updated on Jan 03, 2021 06:32 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Shivani Kumar

‘Thanks to Dr Randeep Guleria’: JP Nadda tweets after recovering from Covid-19

The BJP chief tested Covid-19 positive on December 13, soon after his visit to West Bengal.
After testing Covid-19 positive, JP Nadda was under home isolation since December 13. (Photo: Twitter)
After testing Covid-19 positive, JP Nadda was under home isolation since December 13. (Photo: Twitter)
Updated on Jan 01, 2021 02:34 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Poulomi Ghosh

Possible that Covid-19 UK strain entered India before, says AIIMS director

Though the new strain has entered India, it has not affected India’s number of cases so far, Randeep Guleria said.
Healthcare workers during COVID-19 screening and swab test at Malad in Mumbai on Wednesday.(Satyabrata Tripathy/HT Photo)
Healthcare workers during COVID-19 screening and swab test at Malad in Mumbai on Wednesday.(Satyabrata Tripathy/HT Photo)
Updated on Dec 30, 2020 11:25 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Poulomi Ghosh

Govt to reserve 60% ICU beds in pvt hospitals for Covid care

Justice Navin Chawla expressed the court’s displeasure at the delay by the Delhi government in presenting the statistics regarding the necessity of keeping these beds reserved amid concerns of non-Covid patients not getting critical care.
Health workers check the body temperature of patients recovering at the Sardar Patel Covid Care Center hospital after getting, in New Delhi.(AP)
Health workers check the body temperature of patients recovering at the Sardar Patel Covid Care Center hospital after getting, in New Delhi.(AP)
Updated on Dec 25, 2020 02:36 AM IST
Copy Link
Hindustan Times, New Delhi | ByRicha Banka

Covid-19: Govt to decide on reserving 80% beds in pvt hospitals today

The government further told the court that due to the current evolving situation of a new Covid-19 strain, the government order of reserving the beds would be reviewed on December 23.
A healthcare worker wearing personal protective equipment (PPE) collects a swab sample from a man, amidst the spread of the coronavirus disease (COVID-19), at market area in the old quarters of Delhi.(REUTERS)
A healthcare worker wearing personal protective equipment (PPE) collects a swab sample from a man, amidst the spread of the coronavirus disease (COVID-19), at market area in the old quarters of Delhi.(REUTERS)
Updated on Dec 23, 2020 01:26 AM IST
Copy Link
Hindustan Times, New Delhi | ByRicha Banka

AIIMS nurses call off strike after 2-hour meet with hospital administration

On Monday, around 5,000 nurses of the All India Institute of Medical Sciences (AIIMS) here went on a strike over their long pending demands, including those with regard to the Sixth Central Pay Commission.
Members of AIIMS Nurses Union during their indefinite strike over their long-pending demands, including those concerning the Sixth Central Pay Commission and against contractual appointments, in New Delhi on Tuesday.(PTI Photo)
Members of AIIMS Nurses Union during their indefinite strike over their long-pending demands, including those concerning the Sixth Central Pay Commission and against contractual appointments, in New Delhi on Tuesday.(PTI Photo)
Updated on Dec 15, 2020 11:30 PM IST
Copy Link
New Delhi | ByPress Trust of India | Posted by Kanishka Sarkar

‘Helpless as our demands weren’t met’: AIIMS nurses’ union as indefinite strike enters day 2

The union had launched a strike on Monday over a host of demands, including that related to the 6th Central Pay Commission.
Day 2 of AIIMS nurses’ union strike (ANI)
Day 2 of AIIMS nurses’ union strike (ANI)
Updated on Dec 15, 2020 12:15 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Nearly 3,000 AIIMS nurses go on strike to demand better pay

A government official said that since the demand for salary is not covered under the previous circular, the Central government has agreed to view it as a fresh demand.
The AIIMS administration said that the patients were being managed by resident doctors, senior faculty members and staff.(Mohd Zakir/HT Photo)
The AIIMS administration said that the patients were being managed by resident doctors, senior faculty members and staff.(Mohd Zakir/HT Photo)
Updated on Dec 15, 2020 07:10 AM IST
Copy Link
Hindustan Times, New Delhi | By, New Delhi

Don’t go during the pandemic: AIIMS appeals as nurses’ union threaten strike

The nurses’ union had announced an indefinite strike, starting Monday, over redressal of their demands, including that related to 6th Central Pay Commission.
A health worker in PPE coveralls seen transporting a patient on a stretcher at AIIMS Hospital in New Delhi on November 17, 2020. (Photo by Amal KS/Hindustan Times)
A health worker in PPE coveralls seen transporting a patient on a stretcher at AIIMS Hospital in New Delhi on November 17, 2020. (Photo by Amal KS/Hindustan Times)
Updated on Dec 14, 2020 11:03 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Arpan Rai

Need priority list as vaccine won’t be available for all in the beginning, says AIIMS director

Speaking on the vaccine availability, Guleria said, “In the beginning, it will not be available in sufficient doses to give to everyone. We need a priority list to see that we vaccinate those who’ve high chances of dying due to Covid,” ANI reported.
Once a booster dose is given, the vaccine will give a good amount of antibodies production and protect from the virus for “for a significant amount of time.”(Reuters)
Once a booster dose is given, the vaccine will give a good amount of antibodies production and protect from the virus for “for a significant amount of time.”(Reuters)
Updated on Dec 03, 2020 03:11 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Shivani Kumar

HTLS 2020: There is light at the end of the tunnel, say top Covid experts

The pandemic will start slowing once vaccines are rolled out, said dean of the Brown University School of Public Health, Dr Ashish K Jha.
Dr Guleria, who is also a part of the national committee on vaccination, said he hoped at least 30% to 40% Indians will get the vaccine by the end of next year, with several vaccines in advanced stages of trials.(HT Photo)
Dr Guleria, who is also a part of the national committee on vaccination, said he hoped at least 30% to 40% Indians will get the vaccine by the end of next year, with several vaccines in advanced stages of trials.(HT Photo)
Updated on Nov 20, 2020 05:40 PM IST
Copy Link
Hindustan Times, New Delhi | By

HTLS 2020: Dr Ashish Jha asks people not to worry about long-term immunity from Covid-19

Jha pointed out that the medical and scientific community do not have huge amounts of experience in dealing with SARS-Cov-2 as it is relatively new. He said that people should also not worry themselves with studies concerning antibodies.
Dr Ashish K Jha, Dean, Brown University School of Public Health, in conversation with R Sukumar, Editor-in-Chief, Hindustan Times, during the Hindustan Times Leadership Summit (HTLS) 2020, in New Delhi.(HT Photo)
Dr Ashish K Jha, Dean, Brown University School of Public Health, in conversation with R Sukumar, Editor-in-Chief, Hindustan Times, during the Hindustan Times Leadership Summit (HTLS) 2020, in New Delhi.(HT Photo)
Updated on Nov 20, 2020 01:48 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Shankhyaneel Sarkar

HTLS 2020: Covid virus is very smart, says AIIMS director. He explains why

Dr Guleria said that the percentage of population inoculated by 2021 will depend on the number of Covid-19 vaccines getting regulatory approval early next year and the number of doses they will produce.
Dr Randeep Guleria in conversation with R Sukumar, Editor-in-Chief, Hindustan Times, during the Hindustan Times Leadership Summit (HTLS) 2020.(HT Photo)
Dr Randeep Guleria in conversation with R Sukumar, Editor-in-Chief, Hindustan Times, during the Hindustan Times Leadership Summit (HTLS) 2020.(HT Photo)
Updated on Nov 19, 2020 10:12 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Kunal Gaurav

At HTLS 2020, experts say we will have to learn to live with Covid-19

Randeep Guleria, among the first speakers at HTLS 2020, also cautioned that the challenge would be to reach out to the frontline population for getting them vaccinated against the coronavirus disease.
Dr Randeep Guleria, Director, AIIMS, in conversation with R Sukumar, Editor-in-Chief, Hindustan Times, during the Hindustan Times Leadership Summit (HTLS) 2020, in New Delhi.(HT Photo)
Dr Randeep Guleria, Director, AIIMS, in conversation with R Sukumar, Editor-in-Chief, Hindustan Times, during the Hindustan Times Leadership Summit (HTLS) 2020, in New Delhi.(HT Photo)
Updated on Nov 19, 2020 08:30 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Meenakshi Ray
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, January 20, 2022